KC
GSK icon

Knuff & Co’s GSK GSK Stock Holding History

Knuff & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-800
Closed -$38K – 170
2020
Q3 		$38K Hold
800
– – 0.02% 127
2020
Q2 		$41K Hold
800
– – 0.02% 114
2020
Q1 		$38K Hold
800
– – 0.03% 112
2019
Q4 		$47K Hold
800
– – 0.03% 106
2019
Q3 		$43K Buy
+800
New +$41.2K 0.03% 101

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Knuff & Co's GSK Position: Q4 2020 in Review

Knuff & Co sold out of GSK (GSK) in Q4 2020, closing a stake of 800 shares — an estimated $38K sold.

Knuff & Co first reported a position in GSK in Q3 2019 and held it in 5 quarters. The position peaked at $47K in Q4 2019. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Knuff & Co reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • Knuff & Co sold 800 GSK shares in Q4 2020, an estimated $38K.
  • Knuff & Co first reported a position in GSK in Q3 2019 and held it in 5 quarters.
  • Knuff & Co's GSK position peaked at $47K in Q4 2019.
  • 819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Knuff & Co's 13F filing for Q4 2020, filed 3 Feb 2021.